Study type: In vitro · Status: Verified against declared source
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.
Open forum infectious diseases · 2021
Study scale: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a potentially fatal disease of great global concern for public health.
Abstract only: Open source record
Product or molecular entity relationships
- Thymosin Alpha 1: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a potentially fatal disease of great global concern for public health.
Methods
Correlations between immunophenotyping and cytokines transcriptional activity in coronavirus disease 2019 (COVID-19) individuals and modulation by Thymosin alpha 1 (Tα1) in vitro treatment.
Scale or participants
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a potentially fatal disease of great global concern for public health.
Key findings
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a potentially fatal disease of great global concern for public health.
Limitations and uncertainty
In the last few months, several studies characterized COVID-19 as a disease distinguishable by hyperinflammation and immune-mediated lung injury.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.